leptoprol 5 mg implantat v napolnjeni injekcijski brizgi
sandoz d.d. - levprorelin - implantat - levprorelin 5 mg / 1 brizga - levprorelin
eligard 45 mg prašek in vehikel za raztopino za injiciranje
astellas pharma d.o.o. - levprorelin - prašek in vehikel za raztopino za injiciranje - levprorelin 41,7 mg / 1 brizga - levprorelin
eligard 22,5 mg prašek in vehikel za raztopino za injiciranje
astellas pharma d.o.o. - levprorelin - prašek in vehikel za raztopino za injiciranje - levprorelin 20,87 mg / 1 brizga - levprorelin
eligard 7,5 mg prašek in vehikel za raztopino za injiciranje
astellas pharma d.o.o. - levprorelin - prašek in vehikel za raztopino za injiciranje - levprorelin 6,96 mg / 1 brizga - levprorelin
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatične neoplazme - endokrini terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.